Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Darbepoetin alfa biosimilar - 3SBio

Next Previous
Drug Profile

Darbepoetin alfa biosimilar - 3SBio

Alternative Names: Loncipoetin Alfa; Loncipoetin Alfa Injection; NuPIAO; Recombinant erythropoiesis stimulating protein - 3SBio; Recombinant erythropoietin stimulating protein - 3SBio; Recombinant erythropoietin stimulating protein - Shenyang Sunshine; rESP - 3SBio; SSS-06

Latest Information Update: 14 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator 3SBio
  • Class Antianaemics; Recombinant erythropoietins
  • Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Anaemia

Most Recent Events

  • 31 Mar 2026 Registered for Anaemia in China (IV)
  • 09 Feb 2026 No development reported - Phase-II for Anaemia in China (SC)(3Sbio pipeline, February 2026)
  • 09 Feb 2026 Shenyang Sunshine Pharmaceutical initiates a phase II/III trial for Ananemia (Parenteral, Injection), prior to February 2026 (CTR20250435)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top